previous compound ID: 277 next compound
InChIKey: BRZANEXCSZCZCI-UHFFFAOYSA-N
SMILES: CC1=C(C(=O)N(N1C)C2=CC=CC=C2)NC(=O)C3=CN=CC=C3

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"R Robert" "JW Hanrahan" "SD Macknight" "J Liao" "E Matthes" "D Rotin" "GW Carlile" "DY Thomas" "J Goepp" "B Kus"

chemical graph of compound 277





CID is 4487
synonyms found at PubChem are:
nifenazone, 2139-47-1, Niapyrin, Nifenazon, Nicazane, Nicodone, Nicofesone, Nicophesone, Nicophezon, Nicotazone, Nikofezon, Phenicazone, Thylin, Nicopyron, Nicoreumal, Nicoron, Nicozone, Nikodon, Anicotinoylantipyrine, Nicotinoylaminoantipyrine, Niprazine, N-Antipyrinylnicotinamide, 4-(Nicotinamido)antipyrine, Nicotinamide, N-antipyrinyl-, 4-(Nicotinoylamino)antipyrine, Nicotinic acid 4-antipyrilamide, C17H16N4O2, Nifenazone [INN:BAN], Nifenazonum [INN-Latin], Nifenazona [INN-Spanish], Nicotinic acid, amidophenyldimethylpyrazolone, UNII-8780F0K71U, 1,5-Dimethyl-4-nicotinamido-2-phenyl-3-pyrazolone, EINECS 218-387-1, 4-Nicotinoylamido-1-phenyl-2,3-dimethyl-5-pyrazolone, 8780F0K71U, BRN 0307504, Nicotinsaeureamidophenyldimethylpyrazolons, NCGC00016605-01, CAS-2139-47-1, Nicotinamide, N-(2,3-dimethyl-5-oxo-1-phenyl-3-pyrazolin-4-yl)-, DSSTox_CID_25366, DSSTox_RID_80829, DSSTox_GSID_45366, Nicotinsaeureamidophenyldimethylpyrazolons [German], Nifenazone dihydrochloride, 2,3-dimethyl-4-nicotinamido-1-phenyl-3-pyrazolin-5-on, N-(2,3-Dimethyl-5-oxo-1-phenyl-3-pyrazolin-4-yl)nicotinamid, N-(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)pyridine-3-carboxamide, N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)nicotinamide, N-(2,3-Dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-3-pyridinecarboxamide, SR-01000632824, Nifenazona, Nifenazonum, Dolongan, Reupiron, Nicotinoylantipyrine, Prestwick_582, Spectrum_001575, Nifenazone (JAN/INN), Prestwick0_000225, Prestwick1_000225, Prestwick2_000225, Prestwick3_000225, Spectrum2_000860, Spectrum3_001575, Spectrum4_000848, Spectrum5_000972, N-Nicotinoylaminoantipyrine, AC1L1IA1, Oprea1_385416, SCHEMBL25945, BSPBio_000269, BSPBio_003110, KBioGR_001455, KBioSS_002055, MLS000768954, DivK1c_000546, SPECTRUM1503230, SPBio_000879, SPBio_002190, Nifenazone, analytical standard, BPBio1_000297, CHEMBL1413176, DTXSID7045366, CHEBI:31910, CTK8G1876, HMS501L08, KBio1_000546, KBio2_002055, KBio2_004623, KBio2_007191, KBio3_002610, ZINC57417, BRZANEXCSZCZCI-UHFFFAOYSA-N, MolPort-001-015-123, NINDS_000546, HMS1568N11, HMS1922K15, HMS2095N11, HMS2796P15, HMS3712N11, Pharmakon1600-01503230, Tox21_110519, 2587AH, CCG-40077, NSC758411, STK733507, AKOS001038391, Tox21_110519_1, API0003567, MCULE-1445985424, NSC-758411, IDI1_000546, NCGC00016605-02, NCGC00016605-03, NCGC00016605-04, NCGC00016605-05, NCGC00016605-08, NCGC00095026-01, NCGC00095026-02, NCGC00178289-01, NCGC00178289-02, HY-17475, LS-96379, SMR000433688, ZB002109, SBI-0051796.P002, CS-0009213, D01437, W-2459, AB00052331_09, AB00052331_10, 5-25-14-00153 (Beilstein Handbook Reference), J-014028, SR-01000632824-1, SR-01000632824-3, SR-01000632824-4, BRD-K47407372-001-05-6, BRD-K47407372-001-09-8, BRD-K47407372-001-15-5, N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-nicotinamide, N-(2,3-Dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)nicotinamide, 3-Pyridinecarboxamide, N-(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-, N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)nicotinamide #, N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)pyridine-3-carboxamide, N-(2,3-Dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-3-pyridinecarboxamide (9CI)